Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Version v3.3.4 was released on 2026-01-07 with updates to core sections including Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Design, Study Description, and Study Status. The prior revision v3.3.3 dated 2025-06-04 is removed.
    Difference
    1%
    Check dated 2026-01-14T02:34:47.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    New history entry added: Revision: v3.3.3; removed items from the history include HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-23T13:33:45.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page shows a minor site revision from v3.2.0 to v3.3.2 with no changes to trial data, study descriptions, or links. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:41:15.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Removed the banner about government funding lapses and related operating status updates on the page.
    Difference
    0.8%
    Check dated 2025-11-17T17:38:37.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The update shows minor visual adjustments to the Record History page and the version list; there are no changes to core trial data such as status, description, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T12:30:33.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    12%
    Check dated 2025-10-05T17:27:19.000Z thumbnail image

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.